SAM #NICHD-08610

Antioxidant Therapy Research Services for Smith-Lemli-Opitz Syndrome (SLOS)

This opportunity involves a planned procurement by the National Institutes of Health (NIH), specifically the Section on Molecular Dysmorphology at NICHD, for antioxidant therapy research services related to Smith-Lemli-Opitz Syndrome (SLOS). - The requirement is for specialized research services, not commercial off-the-shelf products. - The work includes: - Development and application of mass spectrometry methods to analyze sterols and oxysterols in serum and cerebrospinal fluid. - Assessment of vitamin E treatment efficacy in SLOS patients. - All travel, labor, and materials are included in the scope. - The intended awardee is the University of Illinois (with Dr. Stephanie Cologna of the University of Chicago performing the assays), indicating a likely sole source or limited competition. - No specific OEMs, part numbers, or commercial products are listed. - The opportunity is focused on research and laboratory assay development rather than equipment procurement. - Potential competitors would be academic or research institutions with expertise in mass spectrometry and SLOS research.

Description

Antioxidant Therapy for Smit-Lemli-Opitiz Syndrone

View original listing